LTC PRODUCTS, INC. – Trademark Portfolio

Entity Type: 03

LTC PRODUCTS, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PELEVERUS. The owner is based in New York, NY.

180 Thompson Street, Suite 5E

New York, NY 10012

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PELEVERUS
PELEVERUS
Registered 1997
RUB-HER
RUB-HER
Cancelled 1993
DAM-HER
DAM-HER
Cancelled 1993

Trademark Classifications

LTC PRODUCTS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does LTC PRODUCTS, INC. have?

LTC PRODUCTS, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.

What trademark classes does LTC PRODUCTS, INC. file in?

LTC PRODUCTS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are LTC PRODUCTS, INC.'s most well-known trademarks?

LTC PRODUCTS, INC.'s registered trademark portfolio includes well-known marks such as PELEVERUS. These are among 1 currently registered trademark in the portfolio.

What is LTC PRODUCTS, INC.'s trademark registration success rate?

LTC PRODUCTS, INC. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.